UPDATE – NeuroPace to Present at the Leerink Partners Global Healthcare Conference
NeuroPace (Nasdaq: NPCE), a medical device company specializing in epilepsy treatment solutions, has announced its participation in the upcoming Leerink Partners 2025 Global Healthcare Conference. The company's management team is scheduled to present on Monday, March 10, 2025, at 4:20pm ET (1:20pm PT) in Miami, FL.
The presentation will be available through a live webcast, with a replay accessible for two weeks afterward through the Events section of NeuroPace's Investor website. Additionally, the management team will be conducting investor meetings throughout the conference.
NeuroPace (Nasdaq: NPCE), un'azienda di dispositivi medici specializzata nelle soluzioni per il trattamento dell'epilessia, ha annunciato la sua partecipazione alla prossima Conferenza Globale sulla Salute 2025 di Leerink Partners. Il team di gestione dell'azienda è programmato per presentare lunedì 10 marzo 2025, alle 16:20 ET (13:20 PT) a Miami, FL.
La presentazione sarà disponibile tramite una diretta web, con una registrazione accessibile per due settimane dopo attraverso la sezione Eventi del sito web per investitori di NeuroPace. Inoltre, il team di gestione condurrà incontri con gli investitori durante tutta la conferenza.
NeuroPace (Nasdaq: NPCE), una empresa de dispositivos médicos especializada en soluciones para el tratamiento de la epilepsia, ha anunciado su participación en la próxima Conferencia Global de Atención Médica 2025 de Leerink Partners. El equipo de gestión de la empresa está programado para presentar el lunes 10 de marzo de 2025, a las 4:20 p.m. ET (1:20 p.m. PT) en Miami, FL.
La presentación estará disponible a través de una transmisión en vivo, con una repetición accesible durante dos semanas después a través de la sección de Eventos del sitio web para inversores de NeuroPace. Además, el equipo de gestión llevará a cabo reuniones con inversores durante toda la conferencia.
NeuroPace (Nasdaq: NPCE)는 간질 치료 솔루션을 전문으로 하는 의료 기기 회사로, 다가오는 Leerink Partners 2025 글로벌 헬스케어 컨퍼런스에 참여할 예정이라고 발표했습니다. 회사의 경영진 팀은 2025년 3월 10일 월요일 오후 4시 20분 ET (오후 1시 20분 PT)에 플로리다주 마이애미에서 발표할 예정입니다.
발표는 실시간 웹캐스트를 통해 제공되며, 이후 2주 동안 NeuroPace의 투자자 웹사이트 이벤트 섹션을 통해 다시 볼 수 있습니다. 또한 경영진 팀은 컨퍼런스 기간 동안 투자자 회의를 진행할 예정입니다.
NeuroPace (Nasdaq: NPCE), une entreprise de dispositifs médicaux spécialisée dans les solutions de traitement de l'épilepsie, a annoncé sa participation à la prochaine Conférence Mondiale sur la Santé 2025 de Leerink Partners. L'équipe de direction de l'entreprise doit faire une présentation le lundi 10 mars 2025, à 16h20 ET (13h20 PT) à Miami, FL.
La présentation sera disponible via un webinaire en direct, avec une rediffusion accessible pendant deux semaines par la suite via la section Événements du site des investisseurs de NeuroPace. De plus, l'équipe de direction tiendra des réunions avec des investisseurs tout au long de la conférence.
NeuroPace (Nasdaq: NPCE), ein Medizintechnikunternehmen, das auf Lösungen zur Behandlung von Epilepsie spezialisiert ist, hat seine Teilnahme an der bevorstehenden Leerink Partners 2025 Global Healthcare Conference bekannt gegeben. Das Management-Team des Unternehmens wird am Montag, den 10. März 2025, um 16:20 Uhr ET (13:20 Uhr PT) in Miami, FL, präsentieren.
Die Präsentation wird über einen Live-Webcast verfügbar sein, mit einer Wiederholung, die zwei Wochen lang über den Bereich Veranstaltungen auf der Investorenseite von NeuroPace zugänglich ist. Darüber hinaus wird das Management-Team während der gesamten Konferenz Investorenmeetings durchführen.
- None.
- None.
MOUNTAIN VIEW, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will present at the Leerink Partners 2025 Global Healthcare Conference at 4:20pm ET (1:20pm PT) on Monday, March 10, 2025, in Miami, FL. Management will also host investor meetings during the conference.
The presentation will be accessible via live webcast here. A webcast replay will be available for two weeks following the presentation in the Events section of NeuroPace’s Investor website at https://investors.neuropace.com.
About NeuroPace, Inc.
Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.
Investor Contact:
Jeremy Feffer
Managing Director
LifeSci Advisors
jfeffer@lifesciadvisors.com
FAQ
When is NeuroPace (NPCE) presenting at the Leerink Partners Healthcare Conference 2025?
How can investors watch NeuroPace's (NPCE) Leerink Conference presentation?
Will NeuroPace (NPCE) management be available for investor meetings at the Leerink Conference?
How long will the replay of NeuroPace's (NPCE) Leerink presentation be available?
